Suppr超能文献

使用RNA测序检测人类基因组表达外显子中的单核苷酸变异

Detection of single nucleotide variations in expressed exons of the human genome using RNA-Seq.

作者信息

Chepelev Iouri, Wei Gang, Tang Qingsong, Zhao Keji

机构信息

Laboratory of Molecular Immunology, National Heart, Lung and Blood Institute, NIH, Bethesda, MD 20892, USA.

出版信息

Nucleic Acids Res. 2009 Sep;37(16):e106. doi: 10.1093/nar/gkp507. Epub 2009 Jun 15.

Abstract

Whole-genome resequencing is still a costly method to detect genetic mutations that lead to altered forms of proteins and may be associated with disease development. Since the majority of disease-related single nucleotide variations (SNVs) are found in protein-coding regions, we propose to identify SNVs in expressed exons of the human genome using the recently developed RNA-Seq technique. We identify 12 176 and 10 621 SNVs, respectively, in Jurkat T cells and CD4(+) T cells from a healthy donor. Interestingly, our data show that one copy of the TAL-1 proto-oncogene has a point mutation in 3' UTR and only the mutant allele is expressed in Jurkat cells. We provide a comprehensive dataset for further understanding the cancer biology of Jurkat cells. Our results indicate that this is a cost-effective and efficient strategy to systematically identify SNVs in the expressed regions of the human genome.

摘要

全基因组重测序仍然是一种成本高昂的方法,用于检测导致蛋白质形式改变且可能与疾病发展相关的基因突变。由于大多数与疾病相关的单核苷酸变异(SNV)存在于蛋白质编码区域,我们建议使用最近开发的RNA测序(RNA-Seq)技术来鉴定人类基因组中表达外显子的SNV。我们分别在来自健康供体的Jurkat T细胞和CD4(+) T细胞中鉴定出12176个和10621个SNV。有趣的是,我们的数据显示,原癌基因TAL-1的一个拷贝在3'非翻译区(UTR)有一个点突变,并且只有突变等位基因在Jurkat细胞中表达。我们提供了一个全面的数据集,以进一步了解Jurkat细胞的癌症生物学特性。我们的结果表明,这是一种经济高效的策略,可用于系统地鉴定人类基因组表达区域中的SNV。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a41/2760790/e38d5649e749/gkp507f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验